HealthDay - THURSDAY, Aug. 21 (HealthDay News) — The osteoporosis drug
Zometa (zoledronic acid) prevented bone loss at 12 months in premenopausal
women undergoing chemotherapy after they had surgery for early stage
breast cancer, a new study found.











August 21st, 2008 at 12:22 pm
[…] Original post by Herbal-Review.com […]